Harris MI, Flegal KM, Cowie CC.
et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose
tolerance in US adults: the Third National Health and Nutrition Examination
Survey, 1988-1994. Diabetes Care.1998;21:518-524.
Tooke JE. Microvascular function in human diabetes: a physiological perspective. Diabetes.1995;44:721-726.
Hsueh WA, Law RE. Diabetes is a vascular disease. J Investig Med.1998;46:387-390.
Morris SJ, Shore AC, Tooke JE. Responses of the skin microcirculation to acetylcholine and sodium
nitroprusside in patients with NIDDM. Diabetologia.1995;38:1337-1344.
Laakso M, Edelman SV, Brechtel G, Baron AD. Impaired insulin-mediated skeletal muscle blood flow in patients with
NIDDM. Diabetes.1992;41:1076-1083.
Jaap AJ, Shore AC, Tooke JE. Relationship of insulin resistance to microvascular dysfunction in
subjects with fasting hyperglycaemia. Diabetologia.1997;40:238-243.
Jaap AJ, Hammersley MS, Shore AC, Tooke JE. Reduced microvascular hyperaemia in subjects at risk of developing
type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia.1994;37:214-216.
Caballero AE, Arora S, Saouaf R.
et al. Microvascular and macrovascular reactivity is reduced in subjects at
risk for type 2 diabetes. Diabetes.1999;48:1856-1862.
Balletshofer BM, Rittig K, Enderle MD.
et al. Endothelial dysfunction is detectable in young normotensive first-degree
relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation.2000;101:1780-1784.
Tooke JE. Methodologies used in the study of the microcirculation in diabetes
mellitus. Diabetes Metab Rev.1993;9:57-70.
Wong TY, Klein R, Klein BEK, Tielsch JM, Hubbard LD, Nieto FJ. Retinal microvascular abnormalities and their relations with hypertension,
cardiovascular diseases and mortality. Surv Ophthalmol.2001;46:59-80.
Hubbard LD, Brothers RJ, King WN.
et al. for the Atherosclerosis Risk in Communities (ARIC) Study Investigators. Methods for evaluation of retinal microvascular abnormalities associated
with hypertension/sclerosis in the Atherosclerosis Risk in Communities (ARIC)
Study. Ophthalmology.1999;106:2269-2280.
Sharrett AR, Hubbard LD, Cooper LS.
et al. Retinal arteriolar diameters and elevated blood pressure: the Atherosclerosis
Risk in Communities Study. Am J Epidemiol.1999;150:263-270.
Klein R, Sharrett AR, Klein BE.
et al. Are retinal arteriolar abnormalities related to atherosclerosis? the
Atherosclerosis Risk in Communities Study. Arterioscler Thromb Vasc Biol.2000;20:1644-1650.
Wong TY, Klein R, Couper DJ.
et al. Retinal microvascular abnormalities and incident stroke: the Atherosclerosis
Risk in Communities Study. Lancet.2001;358:1134-1140.
The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol.1989;129:687-702.
Brancati FL, Kao WH, Folsom AR, Watson RL, Szklo M. Incident type 2 diabetes mellitus in African American and white adults:
the Atherosclerosis Risk in Communities Study. JAMA.2000;283:2253-2259.
Not Available. American Diabetes Association: Clinical Practice Recommendations 1997. Diabetes Care.1997;20(suppl 1):S1-S70.
Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity
in epidemiological studies. Am J Clin Nutr.1982;36:936-942.
Papp AC, Hatzakis H, Bracey A, Wu KK. ARIC hemostasis study, I: development of a blood collection and processing
system suitable for multicenter hemostatic studies. Thromb Haemost.1989;61:15-19.
National Heart, Lung, and Blood Institute, University of North Carolina
School of Public Health ARIC Coordinating Center. Atherosclerosis Risk in Communities Study Operations
Manual No. 2: Cohort Component Procedures. Version 2.0. Chapel Hill: University of North Carolina; 1988.
Burchfiel CM, Tracy RE, Chyou PH, Strong JP. Cardiovascular risk factors and hyalinization of renal arterioles at
autopsy: the Honolulu Heart Program. Arterioscler Thromb Vasc Biol.1997;17:760-768.
Baumbach GL, Heistad DD. Remodeling of cerebral arterioles in chronic hypertension. Hypertension.1989;13:968-972.
Baron AD, Clark MG. Role of blood flow in the regulation of muscle glucose uptake. Annu Rev Nutr.1997;17:487-499.
Laakso M, Edelman SV, Brechtel G, Baron AD. Decreased effect of insulin to stimulate skeletal muscle blood flow
in obese man: a novel mechanism for insulin resistance. J Clin Invest.1990;85:1844-1852.
Hulthen UL, Endre T, Mattiasson I, Berglund G. Insulin and forearm vasodilation in hypertension-prone men. Hypertension.1995;25:214-218.
Feldman RD, Bierbrier GS. Insulin-mediated vasodilation: impairment with increased blood pressure
and body mass. Lancet.1993;342:707-709.
Pell S, D'Alonzo CA. Some aspects of hypertension in diabetes mellitus. JAMA.1967;202:104-110.
Morales PA, Mitchell BD, Valdez RA, Hazuda HP, Stern MP, Haffner SM. Incidence of NIDDM and impaired glucose tolerance in hypertensive subjects:
the San Antonio Heart Study. Diabetes.1993;42:154-161.
Manson JE, Ajani UA, Liu S, Nathan DM, Hennekens CH. A prospective study of cigarette smoking and the incidence of diabetes
mellitus among US male physicians. Am J Med.2000;109:538-542.
Rimm EB, Manson JE, Stampfer MJ.
et al. Cigarette smoking and the risk of diabetes in women. Am J Public Health.1993;83:211-214.
Jaap AJ, Shore AC, Tooke JE. The influence of hypertension on microvascular blood flow and resistance
to flow in the skin of patients with type 2 (non-insulin-dependent) diabetes. Diabet Med.1994;11:883-887.
Schmidt MI, Duncan BB, Sharrett AR.
et al. Markers of inflammation and prediction of diabetes mellitus in adults
(Atherosclerosis Risk in Communities study): a cohort study. Lancet.1999;353:1649-1652.
Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes
mellitus. JAMA.2001;286:327-334.